Results 121 to 130 of about 11,689 (208)

Reactogenicity of Synthetic Hydroxyapatite (HAp) Ceramic Materials Implantedin Rabbits Jaws

Experimental comparing of morphofunctional changes in implant contact tissue with same tissue involved in surgical intervention of same manner without insertion of artificial materials can clarify specific reactogenicity of implant and/or material.
Šalma, Ilze, Šalms, Ģirts, Vētra, Jānis, pilmane, Māra, Bērziņa-Cimdiņa, Līga, Skaģers, Andrejs   +5 more
core  

Safety and reactogenicity of second booster doses for mRNA vaccines

The Lancet Respiratory Medicine, 2023
Wilder-Smith, Annelies, Kochhar, Sonali
openaire   +2 more sources

mRNA and Protein Subunit COVID-19 Vaccine Reactogenicity and Their Relationship to Productivity for Healthcare Workers and First Responders. [PDF]

Open Forum Infect Dis
Yoon SK, Phillips AL, Calhoun S, Odom D, Ziemiecki R, Jackson L, McKell J, Griffin J, Choi JM, Prillaman BA, Campbell R, Hahn B, Warren B, Fix J, Rousculp MD, Ellsworth GL.   +15 more
europepmc   +1 more source

New-age vaccine adjuvants: friend or foe? A major unsolved challenge in adjuvant development is how to achieve a potent adjuvant effect while avoiding reactogenicity or toxicity

, 2007
Older vaccines made from live or killed whole organisms were effective, but suffered from high reactogenicity. As vaccine manufacturers developed safer, less reactogenic subunit vaccines, they found that with lower reactogenicity came reduced vaccine ...
Honda, Y., Heinzel, S., Petrovsky, N., Lyons, A.B.   +3 more
core  

An old foe comes swooping back: Whooping cough resurgence-Okay, now what? [PDF]

PLoS Pathog
Musgrave DL, Creech CB.
europepmc   +1 more source

Self-reported longitudinal COVID-19 vaccination reactogenicity profiles in persons with multiple sclerosis

•SARS-CoV-2 short-term vaccine reactions and reactions after specific vaccine sequences in persons with multiple sclerosis appear consistent with the general population.•Older adults and those treated with sphingosine-1-phosphate receptor modulators were
Crouthamel, Slavka, Mateen, Farrah J., Briggs, Farren B.S., Bebo, Bruce F., Racke, Michael K., Schmidt, Hollie, Currie, Keisha M., McBurney, Robert N., Klein, Phyllis, Buxhoeveden, Stephanie, Siefers, Heather M., Loud, Sara, Fiol, Julie, Kolaczkowski, Laura G.   +13 more
core   +1 more source

IL-1 delineates squalene-based adjuvant efficacy and reactogenicity in a cell-type-specific manner. [PDF]

NPJ Vaccines
Yoshioka Y, Nishinaka-Yoshioka A, Kobiyama K, Hayashi T, Kidani Y, Yanagida Y, Kasahara J, Tsujii K, Asaoka Y, Kuroda N, Kugimiya A, Osawa H, Yoshimura A, Onishi M, Nakagawa T, Ishida S, Omoto S, Nagira M, Coban C, Ishii KJ.   +19 more
europepmc   +1 more source

Safety and health-related quality of life following maternal respiratory syncytial virus (RSV) and diphtheria-tetanus-acellular pertussis (DTaP) vaccinations. [PDF]

Hum Vaccin Immunother
Kitano T, Kurosawa N, Watanabe S, Takeda K, Ishibashi S, Fukui H, Kurose S, Ikeda M, Kano M, Kanzaki G, Sado T, Ohgitani A, Yoshida S.   +12 more
europepmc   +1 more source

AS01_B-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a <i>post-hoc</i> cross-protocol comparison of results from HVTN 100, 107, 120, and 702. [PDF]

Front Immunol
Menezes F, Chen S, Grunenberg N, Malahleha M, Mngadi K, Muyoyeta M, Laher F, Chirenje ZM, Bekker LG, Goepfert P, Gray GE, Tomaras G, McElrath MJ, Kallas E, Roxby AC, Moodie Z.   +15 more
europepmc   +1 more source

Self-amplifying RNA (saRNA) and circular RNA (circRNA) vaccines: Progress, evidence gaps, and translational pathways for durable and scalable immunization. [PDF]

Hum Vaccin Immunother
Okechukwu Paul-Chima U, Michael Ben O, Fabian C O, Jovita Nnenna U, Chinyere N U.   +4 more
europepmc   +1 more source